Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
53.51 USD | -1.58% | +1.08% | -14.78% |
07.05. | Ligand Pharmaceuticals investiert in Agenus zur Finanzierung der Entwicklung von Onkologie-Wirkstoffkandidaten | MT |
01.05. | INCYTE CORPORATION : TD Cowen bekräftigt seine Kaufempfehlung | ZM |
ETFs investiert in Incyte Corporation
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
0,06% | 330 M€ | -.--% | - | |
0,05% | 0 M€ | 0.00% | - | |
0,05% | 0 M€ | +4.95% | - | |
0,05% | 0 M€ | +8.05% | ||
0,05% | 6 M€ | +17.98% | - | |
0,05% | 0 M€ | +6.24% | - | |
0,04% | 276 M€ | +11.40% | - | |
0,04% | 0 M€ | +11.74% | - | |
0,04% | 0 M€ | +18.93% | - | |
0,03% | 0 M€ | +17.73% | ||
0,03% | 0 M€ | +11.27% | - | |
0,03% | 1 174 M€ | +23.54% | ||
0,03% | 273 M€ | -.--% | ||
0,03% | 655 M€ | -.--% | - | |
0,02% | 205 M€ | -.--% | ||
0,02% | 0 M€ | +7.98% | - | |
0,02% | 14 M€ | +16.19% | - | |
0,02% | 0 M€ | +6.03% | - | |
0,02% | 206 M€ | -.--% | ||
0,02% | 0 M€ | +7.83% | - | |
0,02% | 284 M€ | -.--% | ||
0,02% | 1 166 M€ | +0.26% | - | |
0,02% | 607 M€ | +0.05% | - | |
0,02% | 23 M€ | -.--% | - | |
0,02% | 786 M€ | -.--% |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-14.78% | 12.02 Mrd. | |
-3.35% | 88.91 Mrd. | |
+4.08% | 41.25 Mrd. | |
-15.09% | 31.99 Mrd. | |
+52.34% | 24.73 Mrd. | |
-15.13% | 15.54 Mrd. | |
-8.63% | 12.05 Mrd. | |
-40.39% | 12.07 Mrd. | |
+6.22% | 8.84 Mrd. | |
-5.15% | 8.3 Mrd. |
- Börse
- Aktien
- 896133 Aktie
- ETFs Incyte Corporation